The actor backed Ozempic in an interview while saying exercise has no shortcut. Doctors break down whether his advice holds up.
Recap by typeshit. Post by Facebook on Facebook.
A BusinessWorld piece on FDA worries about unapproved GLP-1 weight loss drugs, including retatrutide, which is still in trials. Few details were available.
Hecht walks through studies raising concerns that Ozempic and Wegovy may be tied to a rare optic nerve problem that can affect vision.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
BioPharma Dive reports the recall adds to safety worries about knockoff weight loss drugs, which stay popular despite FDA warnings and pressure from Lilly and Novo.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
A guide covers who qualifies for the lower price, how to bring it up with a doctor, and delivery options that cut costs further.
Loading…